As of 21 Oct 2026, PsyLabs has raised $2.6M across 1 verified round on record; latest: US$2,599,896 funding round, announced 21 Oct 2026.
A neuroplastogen active pharmaceutical ingredient development company
psylabs.lifeTexas
4 sources · checked 1 time, last 1h ago
The sources announce an additional backstop investment in PsyLabs, not a named stage. No lead investor is stated; Psyence Biomed II Corp. is identified as the subscriber.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $2.6M $5M to date at US$54 million pre-money valuation | 2026-10-21 | not stated | 3 outlets. #79 in Trending |
4 sources · checked 1 time, last 1h ago [ VERIFIED ] read against 4 sources The sources announce an additional backstop investment in PsyLabs, not a named stage. No lead investor is stated; Psyence Biomed II Corp. is identified as the subscriber. [ BUILT WITH ]·[ SEARCH ]found on a watched publisher·[ SCRAPE ]4 pages read: globenewswire.com, markets.businessinsider.com, manilatimes.net·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 4 sources·[ BRANDING ]logo and colour from the homepage | ||||